| Product Code: ETC7623647 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Asthma and COPD Drug Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Asthma and COPD Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Asthma and COPD Drug Market - Industry Life Cycle |
3.4 Ireland Asthma and COPD Drug Market - Porter's Five Forces |
3.5 Ireland Asthma and COPD Drug Market Revenues & Volume Share, By Diseses, 2021 & 2031F |
3.6 Ireland Asthma and COPD Drug Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
4 Ireland Asthma and COPD Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of asthma and COPD in Ireland |
4.2.2 Growing awareness about respiratory diseases and available treatment options |
4.2.3 Technological advancements in the development of asthma and COPD drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Ireland |
4.3.2 High cost associated with the development and marketing of asthma and COPD drugs |
4.3.3 Competition from generic drug manufacturers |
5 Ireland Asthma and COPD Drug Market Trends |
6 Ireland Asthma and COPD Drug Market, By Types |
6.1 Ireland Asthma and COPD Drug Market, By Diseses |
6.1.1 Overview and Analysis |
6.1.2 Ireland Asthma and COPD Drug Market Revenues & Volume, By Diseses, 2021- 2031F |
6.1.3 Ireland Asthma and COPD Drug Market Revenues & Volume, By Asthma, 2021- 2031F |
6.1.4 Ireland Asthma and COPD Drug Market Revenues & Volume, By COPD, 2021- 2031F |
6.2 Ireland Asthma and COPD Drug Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 Ireland Asthma and COPD Drug Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.2.3 Ireland Asthma and COPD Drug Market Revenues & Volume, By Short Acting Beta Agonists (SABA), 2021- 2031F |
6.2.4 Ireland Asthma and COPD Drug Market Revenues & Volume, By Long Acting Beta Agonists (LABA), 2021- 2031F |
6.2.5 Ireland Asthma and COPD Drug Market Revenues & Volume, By Leukotriene Antagonists (LTA), 2021- 2031F |
6.2.6 Ireland Asthma and COPD Drug Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.2.7 Ireland Asthma and COPD Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Asthma and COPD Drug Market Import-Export Trade Statistics |
7.1 Ireland Asthma and COPD Drug Market Export to Major Countries |
7.2 Ireland Asthma and COPD Drug Market Imports from Major Countries |
8 Ireland Asthma and COPD Drug Market Key Performance Indicators |
8.1 Number of patients diagnosed with asthma and COPD in Ireland |
8.2 Adoption rate of advanced treatment options for asthma and COPD |
8.3 Research and development investment in innovative drug therapies for respiratory diseases |
9 Ireland Asthma and COPD Drug Market - Opportunity Assessment |
9.1 Ireland Asthma and COPD Drug Market Opportunity Assessment, By Diseses, 2021 & 2031F |
9.2 Ireland Asthma and COPD Drug Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
10 Ireland Asthma and COPD Drug Market - Competitive Landscape |
10.1 Ireland Asthma and COPD Drug Market Revenue Share, By Companies, 2024 |
10.2 Ireland Asthma and COPD Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here